FDA inspection

Hetero Drugs Limited Inhouse R&D Unit: FDA inspection ending Sep 7, 2017

FDA inspection 1030268 · No Action Indicated (NAI) · Hyderabad

Key facts

Inspection ID 1030268
Firm Hetero Drugs Limited Inhouse R&D Unit
FEI number 3009307611
Address Plot Nos. B 80 And 81, Apie, Balanagar
City Hyderabad
Fiscal year 2017
Inspection end date Sep 7, 2017
Classification No Action Indicated (NAI)
Project area Generic Drug Evaluation
Product type Drugs

At a glance

  • None Citations
  • None Posted citations
  • No Warning letter followed
  • Yes Form FDA 483 issued
  • No Establishment inspection report (EIR) exists
  • 1–9 Inspections at this FEI

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About FDA inspections

FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.

Source: U.S. Food and Drug Administration (FDA), inspection classification data

Browse all FDA inspections